A. M. González-Nogal, P. Cuadrado, M. A. Sarmentero
FULL PAPER
(121 MHz, CDCl3): δ = 29.54 ppm. C15H16NO2P (273.09): calcd.
21.7, 21.8, 25.2, 44.9, 46.7 (d, J = 57.1 Hz), 128.2 (d, J = 11.4 Hz),
C 65.93, H 5.90, N 5.13; found C 66.20, H 5.65, N 4.81.
130.8, 131.8 (d,
6.7 Hz) ppm. 31P NMR (121 MHz, CDCl3): δ = 27.98 ppm. IR
(film): ν = 3053, 1591, 1437, 1265, 1193 cm–1. C H NO PS
(469.15): calcd. C 63.95, H 6.01, N 2.98; found C 64.21, H 5.86, N
2.74.
J = 8.8 Hz), 133.3, 144.4, 161.9 (d, J =
(Z,E)-[2-(Hydroximino)hexyl]diphenylphosphane Oxide (6b): Yield
195 mg (62%). Rf = 0.32 (AcOEt). Z isomer: 65 mg (41%). 1H
NMR (300 MHz, CDCl3): δ = 0.85 (t, J = 7.3 Hz, 3 H), 1.20 (m,
2 H), 1.37 (m, 2 H), 2. 38 (t, J = 7.6 Hz, 2 H), 3.29 (d, J = 14.2 Hz,
2 H), 7.33–7.45 (m, 6 H), 7.63–7.82 (m, 4 H), 10.29 (br. s, 1 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 13.5, 22.7, 27.3, 34.4, 36.0 (d, J
= 67.7 Hz), 128.8 (d, J = 12.1 Hz), 130.1 (d, J = 8.9 Hz), 131.5,
132.8 (d, J = 100.4 Hz), 153.7 ppm. 31P NMR (121 MHz, CDCl3):
δ = 29.76. E isomer: 130 mg (41%) ppm. 1H NMR (300 MHz,
CDCl3): δ = 0.76 (t, J = 7.3 Hz, 3 H), 1.22 (m, 2 H), 1.40 (m, 2
H), 2. 28 (t, J = 6.8 Hz, 2 H), 3.60 (d, J = 15.4 Hz, 2 H), 7.33–7.45
(m, 6 H), 7.63–7.82 (m, 4 H), 10.59 (br. s, 1 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 13.8, 22.0, 28.1, 29.9 (d, J = 66.0 Hz), 34.4,
128.3 (d, J = 12.2 Hz), 130.8 (d, J = 9.8 Hz), 131.8 (d, J = 2.1 Hz),
132.4 (d, J = 101.2 Hz), 151.8 (d, J = 7.5 Hz) ppm. 31P NMR
(121 MHz, CDCl3): δ = 29.58 ppm. C18H22NO2P (315.14): calcd.
C 68.56, H 7.03, N 4.44; found C 68.81, H 7.36, N 4.71.
˜
25 28
4
(E)-2-Phenyl-[2-(p-tolylsulfonyloximino)ethyl]diphenylphosphane
Oxide (7c): Yield 205 mg (42%). Rf = 0.45 (AcOEt); m.p. 142–
144 °C (from pyridine/water). 1H NMR (300 MHz, CDCl3): δ =
2.44 (s, 3 H), 4.01 (d, J = 15.4 Hz, 2 H), 7.23 (m, 3 H), 7.45 (m, 6
H), 7.52–7.83 (m, 5 H) ppm. 31P NMR (121 MHz, CDCl3): δ =
26.18 ppm. C27H24NO4PS (489.12): calcd. C 66.25, H 4.94, N 2.86;
found C 65.91, H 5.14, N 4.68.
Synthesis of 2-(Diphenylphosphanyl)-3-methyl-2H-azirine (8): Tri-
ethylamine (2 mmol, 0.258 mL) was added to a solution of the N-
tosyloxime 7a (1 mmol) in dry THF (5 mL) at 0 °C. After stirring
for 10 h at this temperature, the mixture was diluted with CH2Cl2
and washed with a solution of HCl (2 ) and with water. The or-
ganic layer was dried (MgSO4), and solvents were evaporated under
reduced pressure. The crude product was purified by crystallisation
from hexane/CH2Cl2 to give 8 (234 mg, 92%) as a white solid; m.p.
(E)-[2-(Hydroximino)-2-(phenyl)ethyl]diphenylphosphane Oxide (6c):
Yield 187 mg (56%). Rf = 0.41 (AcOEt); m.p. 183–185 °C (from
hexane/AcOEt). 1H NMR (300 MHz, CDCl3): δ = 4.05 (d, J =
15.5 Hz, 2 H), 7.20 (m, 3 H), 7.50 (m, 6 H), 7.60 (m, 2 H), 7.80
(m, 4 H), 11.51 (br. s, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
28.9 (d, J = 64.4 Hz), 126.4, 128.8 (d, J = 11.7 Hz) 130.3, 130.9 (d,
J = 9.3 Hz), 131.6, 132.8, 134.0 (d, J = 98.8 Hz), 135.8, 149.0 (d,
J = 9.2 Hz) ppm. 31P NMR (121 MHz, CDCl3): δ = 28.54 ppm.
C20H18NO2P (335.11): calcd. C 71.63, H 5.41, N 4.18; found C
71.31, H 5.73, N 4.42.
1
98–99 °C. H NMR (300 MHz, CDCl3): δ = 2.24 (d, J = 36.6 Hz,
1 H), 2.43 (s, 3 H), 7.51 (m, 6 H), 7.73 (m, 4 H) ppm. 31P NMR
(121 MHz, CDCl3): δ = 30.56 ppm. C15H14NOP (255.08): calcd. C
70.58, H 5.53, N 5.49; found C 70.82, H 5.40, N 5.75.
Acknowledgments
We thank the Spanish Ministerio de Ciencia y Tecnología (MCYT)
for supporting this work.
Preparation of N-Tosyloximes. Typical Procedure: Tosyl chloride
(1.03 mmol) was added at 0 °C to a stirred solution of an oxime
6a–c (1 mmol) in dry pyridine (1 mL), and stirring was continued
for 1 h. The mixture was allowed to warm to room temperature
and stirred for 1 h. Quenching with ice water (13 mL) afforded a
white precipitate, which was isolated by filtration in vacuo and
washed with water several times. The following products were ob-
tained.
[1] P. F. Hudrlik, A. M. Hudrlik, in Advances in Silicon Chemistry.
α,β-Epoxysilanes (Ed.: G. L Larson), JAI Press, London, 1993,
vol. 2.
[2] A. Nishida, S. Masakatsu, S. Ikegami, Tetrahedron Lett. 1981,
22, 4819–4822.
[3] J. A. Soderquist, C. López, Tetrahedron Lett. 1991, 32, 6305–
6306.
(Z,E)-[2-(p-Tolylsulfonyloximino)propyl]diphenylphosphane Oxide
(7a): Yield 298 mg (70%). Rf = 0.35 (AcOEt); m.p. 130–133 °C
(from pyridine/water).
[4] a) J. B. Lambert, G. Wang, D. H. Teramura, J. Org. Chem.
1988, 53, 5422–5428; b) J. B. Lambert, G. Wang, Tetrahedron
Lett. 1988, 29, 2551–2554.
Z
isomer: 43 mg (10%). 1H NMR
[5] J. M. Chong, E. K. Mar, J. Org. Chem. 1992, 57, 46–49.
[6] M. Lautens, P. H. M. Delanghe, J. B. Goh, C. H. Zhang, J. Org.
Chem. 1995, 60, 4213–4227.
(300 MHz, CDCl3): δ = 2.15 (d, J = 1.8 Hz, 3 H), 2.43 (s, 3 H),
3.58 (d, J = 14.7 Hz, 2 H), 7.20–7.81 (m, 14 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 17.2, 21.9, 34.4 (d, J = 64.5 Hz), 128.2,
130.4, 131.5, 132.5, 144.9, 159.8 ppm. 31P NMR (121 MHz,
CDCl3): δ = 27.05. E isomer: 255 mg (60%) ppm. 1H NMR
(300 MHz, CDCl3): δ = 2.11 (d, J = 1.8 Hz, 3 H), 2.47 (s, 3 H),
3.32 (d, J = 13.9 Hz, 2 H), 7.20–7.81 (m, 14 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 17.3, 21.7, 38.0 (d, J = 63.3 Hz), 128.2,
130.4, 131.5, 132.5, 144.8, 161.9 ppm. 31P NMR (121 MHz,
[7] P. Cuadrado, A. M. González-Nogal, Tetrahedron Lett. 2001,
42, 8993–8996.
[8] P. Cuadrado, A. M. González-Nogal, Tetrahedron Lett. 2000,
41, 1111–1114.
[9] a) P. Cuadrado, A. M. González-Nogal, Tetrahedron Lett.
1997, 38, 8117–8120; b) P. Cuadrado, A. M. González-Nogal,
M. A. Sarmentero, Chem. Eur. J. 2004, 10, 4491–4497.
[10] a) A. Barbero, P. Cuadrado, I. Fleming, A. M. González-No-
gal, F. J. Pulido, J. Chem. Soc., Chem. Commun. 1992, 351–
353; b) A. Barbero, P. Cuadrado, I. Fleming, A. M. González-
Nogal, F. J. Pulido, J. Chem. Soc. Perkin Trans. 1 1993, 1657–
1662; c) A. Barbero, P. Cuadrado, I. Fleming, A. M. González-
Nogal, F. J. Pulido, A. Sánchez, J. Chem. Soc. Perkin Trans. 1
1995, 1525–1532.
[11] a) A. Barbero, P. Cuadrado, I. Fleming, A. M. González-No-
gal, F. J. Pulido, J. Chem. Soc., Chem. Commun. 1990, 1030–
1031; b) A. Barbero, P. Cuadrado, I. Fleming, A. M. González-
Nogal, F. J. Pulido, J. Chem. Soc. Perkin Trans. 1 1992, 327–
331.
CDCl ): δ = 27.95 ppm. IR (film): ν = 3052, 1600, 1470, 1262,
˜
3
1192 cm–1. C22H22NO4PS (427.10): calcd. C 61.82, H 5.19, N 3.28;
found C 61.55, H 5.36, N 3.47.
(Z,E)-[2-(p-Tolylsulfonyloximino)hexyl]diphenylphosphane
Oxide
(7b): Yield 253 mg (54%). Rf = 0.41 (AcOEt). Z isomer: 64 mg
(14%). 1H NMR (300 MHz, CDCl3): δ = 0.84 (t, J = 7.3 Hz, 3 H),
1.14 (m, 2 H), 1.42 (m, 2 H), 1.99 (s, 3 H), 2. 36 (t, J = 7.3 Hz, 2
H), 3.61 (d, J = 15.3 Hz, 2 H), 7.33–7.45 (m, 8 H), 7.63–7.83 (m,
6 H) ppm. 31P NMR (121 MHz, CDCl3): δ = 27.70 ppm. E isomer:
1
189 mg (40%) ppm. H NMR (300 MHz, CDCl3): δ = 0.78 (t, J =
7.2 Hz, 3 H), 1.14 (m, 2 H), 1.42 (m, 2 H), 2.00 (s, 3 H), 2. 58 (t,
J = 7.3 Hz, 2 H), 3.58 (d, J = 15.1 Hz, 2 H), 7.33–7.45 (m, 8 H),
7.63–7.83 (m, 6 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.7,
[12] a) P. Braunstein, Chem. Rev. 2006, 106, 134–159.
[13] a) A. Padwa in Comprehensive Organic Synthesis (Eds.: B.
Trost, I. Fleming, M. F. Semmelhack), Pergamon, Oxford,
858
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 850–859